Summary slide.png (112.94 kB)

A Review of Two Regulatory Approved Anti-CD19 CAR T-Cell Therapies in Diffuse Large B-Cell Lymphoma: Why Are Indirect Treatment Comparisons Not Feasible?

Download (112.94 kB)
figure
posted on 04.06.2020 by Jie Zhang, Junlong Li, Qiufei Ma, Hongbo Yang, James Signorovitch, Eric Wu

The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).

© The authors, CC-BY-NC 2020.


History

Exports